Ian Read began his career with Pfizer in 1978 as an operational auditor. He worked in Latin America through 1995 holding positions ranging from CFO of Pfizer Mexico (Pfizer's largest subsidiary in Latin America) to country manager of Brazil. In 1996, he was appointed president of the Pfizer International Pharmaceuticals Group, Latin America/Canada. He assumed the position of Executive Vice President -- Europe/Canada in May 2000, added the responsibilities for Africa/Middle East region as of January 2004 and responsibilities for Latin America in March 2006. He was named Vice President of Pfizer in 2001 and promoted to President of Worldwide Pharmaceutical Operations in 2006. He is a member of the Pfizer Leadership Team. On 7 December 2010, he became the Chief Executive Officer of Pfizer.
Pfizer, Inc. is an American multinational pharmaceutical corporation headquartered in New York City, and with its research headquarters in Groton, Connecticut, United States. It is one of the world's largest pharmaceutical companies by revenues.
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin for neuropathic pain/fibromyalgia); Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib), an anti-inflammatory drug.